Vicky Hsu

FDA Approval Summary: Ivosidenib for Relapsed or Refractory Acute Myeloid Leukemia with an Isocitrate Dehydrogenase-1 Mutation

Sarah E. Dorff, K. Goldberg, R. Pazdur, 2019, Clinical Cancer Research.

Advancing Predictions of Tissue and Intracellular Drug Concentrations Using In Vitro, Imaging and Physiologically Based Pharmacokinetic Modeling Approaches

Yuichi Sugiyama, Aleksandra Galetin, Jan Snoeys, 2018, Clinical pharmacology and therapeutics.

Predictive Performance of Physiologically-Based Pharmacokinetic Models in Predicting Drug–Drug Interactions Involving Enzyme Modulation

P. Zhao, C. Hsueh, V. Hsu, 2018, Clinical Pharmacokinetics.

The Application of Physiologically Based Pharmacokinetic Modeling to Predict the Role of Drug Transporters: Scientific and Regulatory Perspectives

Lei Zhang, Vikram Sinha, Ping Zhao, 2016, Journal of clinical pharmacology.

Predicting the Effect of CYP3A Inducers on the Pharmacokinetics of Substrate Drugs Using Physiologically Based Pharmacokinetic (PBPK) Modeling: An Analysis of PBPK Submissions to the US FDA

Vikram Sinha, Ping Zhao, Christian Wagner, 2016, Clinical Pharmacokinetics.

Application of Physiologically Based Pharmacokinetic (PBPK) Modeling to Support Dose Selection: Report of an FDA Public Workshop on PBPK

Shiew-Mei Huang, S‐M Huang, P. Zhao, 2015, CPT: pharmacometrics & systems pharmacology.

Towards Quantitation of the Effects of Renal Impairment and Probenecid Inhibition on Kidney Uptake and Efflux Transporters, Using Physiologically Based Pharmacokinetic Modelling and Simulations

Lei Zhang, Shiew-Mei Huang, Ping Zhao, 2014, Clinical Pharmacokinetics.

Predicting the Effect of Cytochrome P450 Inhibitors on Substrate Drugs: Analysis of Physiologically Based Pharmacokinetic Modeling Submissions to the US Food and Drug Administration

Lei Zhang, Vikram Sinha, Ping Zhao, 2014, Clinical Pharmacokinetics.

FDA Approval Summary: Enfortumab Vedotin for Locally Advanced or Metastatic Urothelial Carcinoma

Sarah E. Dorff, K. Goldberg, R. Pazdur, 2020, Clinical Cancer Research.